G
Giampaolo Tortora
Researcher at University of Verona
Publications - 537
Citations - 34580
Giampaolo Tortora is an academic researcher from University of Verona. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 74, co-authored 429 publications receiving 29203 citations. Previous affiliations of Giampaolo Tortora include The Catholic University of America & Seconda Università degli Studi di Napoli.
Papers
More filters
Journal ArticleDOI
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer
Luisa Carbognin,Isabella Sperduti,Matteo Brunelli,Lisa Marcolini,Rolando Nortilli,Sara Pilotto,Ilaria Zampiva,Sara Merler,Elena Fiorio,Elisa Filippi,Erminia Manfrin,Francesca Pellini,Franco Bonetti,Giovanni Paolo Pollini,Giampaolo Tortora,Emilio Bria +15 more
TL;DR: Despite the retrospective and exploratory nature of the study, Ki67 was able to significantly discriminate the prognosis of patients with ILC, and the effect was more pronounced for patients with ‘pure’ ILC.
Journal ArticleDOI
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis.
Chiara Ciccarese,Roberto Iacovelli,Cora N. Sternberg,Silke Gillessen,Giampaolo Tortora,Karim Fizazi +5 more
TL;DR: In this paper , the authors evaluated whether the addition of an androgen receptor signalling pathway inhibitor (ARSi) to androgen-deprivation therapy (ADT) improves outcomes of mCSPC patients treated with docetaxel.
Journal ArticleDOI
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research.
Valentina Zambonin,Alessandro De Toma,Luisa Carbognin,Rolando Nortilli,Elena Fiorio,Veronica Parolin,Sara Pilotto,Federica Cuppone,Francesca Pellini,Davide Lombardi,Giovanni Paolo Pollini,Giampaolo Tortora,Emilio Bria +12 more
TL;DR: This study reviews the available clinical trials exploring the potential effectiveness of bevacizumab in BC, regardless of the disease setting and concludes that the current absence of evidence that pCR is a trial-level surrogate for survival requires waiting for long-term results.
Journal ArticleDOI
High-dose recombinant interleukin-2/verapamil combination in advanced cancer
Pierosandro Tagliaferri,Pierpaolo Correale,Michele Mottola,G. De Simone,Vincenzo Montesarchio,Elide Matano,A Rea,Alessandro Morabito,M. Famiani,Fortunato Ciardiello,Giampaolo Tortora,Michele Caraglia,C. Barile,Giovannella Palmieri,Ar Bianco +14 more
Journal ArticleDOI
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
Andrea Botticelli,Giulia Pomati,Alessio Cirillo,Simone Scagnoli,Simona Pisegna,A. Chiavassa,Ernesto Rossi,Giovanni Schinzari,Giampaolo Tortora,Francesca Di Pietro,Bruna Cerbelli,Alessandra Di Filippo,S. Amirhassankhani,A. Scala,Ilaria Grazia Zizzari,Enrico Cortesi,Silverio Tomao,Marianna Nuti,Silvia Mezi,Paolo Marchetti +19 more
TL;DR: In this paper , the authors defined an immune profile predicting the response to immune checkpoint inhibitors (ICIs) in patients with advanced solid tumors, who underwent ICI treatment were enrolled in a prospective study.